{"id":"W4307142137","doi":"10.1016/j.ijrobp.2022.07.1516","title":"KEYNOTE-867: Phase 3, Randomized, Placebo-Controlled Study of Stereotactic Body Radiotherapy (SBRT) with or without Pembrolizumab in Patients with Unresected Stage I or II Non–Small-Cell Lung Cancer (NSCLC)","year":2022,"lang":"en","type":"article","venue":"International Journal of Radiation Oncology*Biology*Physics","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"ca_institutions":"Kingston General Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Clinical endpoint; Stage (stratigraphy); Lung cancer; Placebo; Radiation therapy; Oncology; Internal medicine; Surgery; Randomized controlled trial; Cancer; Pathology; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001481745,0.002002867,0.003030993,0.000454406,0.0005637454,0.001212945,0.001267165,0.001948108,0.008997122],"category_scores_gemma":[0.001140411,0.0008576008,0.002272921,0.0004290107,0.001211919,0.001098511,0.000374499,0.004631294,0.002051268],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006997025,"about_ca_system_score_gemma":0.001459739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001383561,"about_ca_topic_score_gemma":0.00355081,"domain_scores_codex":[0.9996029,0.0001884157,0.00002125739,0.00007559009,0.00003041246,0.00008154326],"domain_scores_gemma":[0.9995291,0.0001179887,0.00009042727,0.00004458241,0.00004072986,0.0001771257],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9713892,0.008052337,0.0003491655,0.000878955,0.001211156,0.00003297083,0.00005810893,0.0004009206,0.004764523,0.0001556256,0.001422005,0.01128509],"study_design_scores_gemma":[0.9672244,0.03075253,0.0006851158,0.00001500127,0.0003114482,0.0000150792,0.00001414603,0.0002062137,0.0003110226,0.0000733374,0.0003825028,0.000009369272],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9738668,0.005580562,0.001650724,0.001073812,0.001218507,0.007831973,0.003049061,0.0004783319,0.00525022],"genre_scores_gemma":[0.9703889,0.004057786,0.003007382,0.002990097,0.0005818259,0.008063355,0.002758206,0.00008819453,0.008064086],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008997122,"threshold_uncertainty_score":0.03009832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01256781853907447,"score_gpt":0.3401551823358004,"score_spread":0.327587363796726,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}